Reversal of Cisplatin and Multidrug Resistance by Ribozyme-Mediated Glutathione Suppression

This publication has 52 references indexed in Scilit:

• Overexpression of glutathione S-transferase π enhances the adduct formation of cisplatin with glutathione in human cancer cells
  Free Radical Research, 1999
• Hammerhead Ribozymes against γ-Glutamylcysteine Synthetase mRNA Down-Regulate Intracellular Glutathione Concentration of Mouse Islet Cells
  Biochemical and Biophysical Research Communications, 1998
• Significance of glutathione S-transferase-π as a tumor marker in patients with oral cancer
  Cancer, 1992
• High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.
  Proceedings of the National Academy of Sciences, 1992
• Potentiation of Azidothymidine Cytotoxicity in Cisplatin-resistant Human Ovarian Carcinoma Cells
  Cancer Communications, 1990
• Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells.
  Proceedings of the National Academy of Sciences, 1988
• Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.
  Proceedings of the National Academy of Sciences, 1987
• Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells.
  Proceedings of the National Academy of Sciences, 1985
• Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies
  Nature, 1985
• Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines
  Science, 1983